Matches in SemOpenAlex for { <https://semopenalex.org/work/W77399336> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W77399336 endingPage "32" @default.
- W77399336 startingPage "27" @default.
- W77399336 abstract "The US Food and Drug Administration (FDA) is considering reclassifying oral contraceptives (OCs) as an over-the-counter (OTC) drug. Family planning providers do not agree on whether making OCs an OTC drug would hurt or benefit US women. Since OC use currently requires a physician's approval, some providers believe that OCs are geographically, economically, and often culturally inaccessible to many women. Others feel that OTC status would result in incorrect use and an increase in unplanned pregnancies. Some argue that giving OCs OTC status would increase access to adolescents and low-income women, and therefore reduce unwanted pregnancies. Yet, Medicaid pays for OCs but not OTCs. Low-income women already have access to OCs at reduced rates at family planning clinics. If OCs achieve OTC status, FDA needs to come up with a way for pharmacies, other sales outlets, and labels to provide the instructions and counseling about nuisance and serious side effects once supplied by clinicians. This would be difficult because instructions are extensive and complex. The fact that 1 in 8 people in the US is illiterate makes it hard to provide adequate instructions on labels. Consequences of improper use are substantial: unwanted pregnancy, psychological stress, health risks from an abortion, risk of mortality from childbirth. Women might stop having the routine gynecological examinations now required for the prescription, so clinicians would not be able to screen for contraindications, sexually transmitted diseases (STDs), and AIDS or provide advice about condom use to prevent STDs and AIDS. This effect would adversely affect public health. Industry is concerned about increased liability if women do not use OCs correctly. Industry is largely staying out of the debate, however. Others are concerned that OTC OCs would cost more to market. A pilot model program is needed to determine whether reclassification would improve access and long-term maintenance on OCs. More research is needed before FDA grants OCs OTC status." @default.
- W77399336 created "2016-06-24" @default.
- W77399336 creator A5088971007 @default.
- W77399336 date "1993-03-01" @default.
- W77399336 modified "2023-09-23" @default.
- W77399336 title "Should oral contraceptives be sold over-the-counter?" @default.
- W77399336 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12319537" @default.
- W77399336 hasPublicationYear "1993" @default.
- W77399336 type Work @default.
- W77399336 sameAs 77399336 @default.
- W77399336 citedByCount "2" @default.
- W77399336 countsByYear W773993362013 @default.
- W77399336 crossrefType "journal-article" @default.
- W77399336 hasAuthorship W77399336A5088971007 @default.
- W77399336 hasConcept C104863432 @default.
- W77399336 hasConcept C138816342 @default.
- W77399336 hasConcept C159110408 @default.
- W77399336 hasConcept C160050368 @default.
- W77399336 hasConcept C2426938 @default.
- W77399336 hasConcept C2776983459 @default.
- W77399336 hasConcept C2777988657 @default.
- W77399336 hasConcept C2778642596 @default.
- W77399336 hasConcept C2779076696 @default.
- W77399336 hasConcept C2779234561 @default.
- W77399336 hasConcept C2779379456 @default.
- W77399336 hasConcept C2908647359 @default.
- W77399336 hasConcept C2986817661 @default.
- W77399336 hasConcept C3013748606 @default.
- W77399336 hasConcept C512399662 @default.
- W77399336 hasConcept C54355233 @default.
- W77399336 hasConcept C71924100 @default.
- W77399336 hasConcept C86803240 @default.
- W77399336 hasConcept C99454951 @default.
- W77399336 hasConceptScore W77399336C104863432 @default.
- W77399336 hasConceptScore W77399336C138816342 @default.
- W77399336 hasConceptScore W77399336C159110408 @default.
- W77399336 hasConceptScore W77399336C160050368 @default.
- W77399336 hasConceptScore W77399336C2426938 @default.
- W77399336 hasConceptScore W77399336C2776983459 @default.
- W77399336 hasConceptScore W77399336C2777988657 @default.
- W77399336 hasConceptScore W77399336C2778642596 @default.
- W77399336 hasConceptScore W77399336C2779076696 @default.
- W77399336 hasConceptScore W77399336C2779234561 @default.
- W77399336 hasConceptScore W77399336C2779379456 @default.
- W77399336 hasConceptScore W77399336C2908647359 @default.
- W77399336 hasConceptScore W77399336C2986817661 @default.
- W77399336 hasConceptScore W77399336C3013748606 @default.
- W77399336 hasConceptScore W77399336C512399662 @default.
- W77399336 hasConceptScore W77399336C54355233 @default.
- W77399336 hasConceptScore W77399336C71924100 @default.
- W77399336 hasConceptScore W77399336C86803240 @default.
- W77399336 hasConceptScore W77399336C99454951 @default.
- W77399336 hasIssue "2" @default.
- W77399336 hasLocation W773993361 @default.
- W77399336 hasOpenAccess W77399336 @default.
- W77399336 hasPrimaryLocation W773993361 @default.
- W77399336 hasRelatedWork W2090947118 @default.
- W77399336 hasRelatedWork W2133768396 @default.
- W77399336 hasRelatedWork W2162375994 @default.
- W77399336 hasRelatedWork W2279518831 @default.
- W77399336 hasRelatedWork W2310329654 @default.
- W77399336 hasRelatedWork W2413568643 @default.
- W77399336 hasRelatedWork W256921319 @default.
- W77399336 hasRelatedWork W2984776489 @default.
- W77399336 hasRelatedWork W2277966541 @default.
- W77399336 hasRelatedWork W235620089 @default.
- W77399336 hasVolume "7" @default.
- W77399336 isParatext "false" @default.
- W77399336 isRetracted "false" @default.
- W77399336 magId "77399336" @default.
- W77399336 workType "article" @default.